Glucotrack Inc (GCTK) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Glucotrack Inc   (NASDAQ: GCTK)


Glucotrack Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Glucotrack Inc's ROI in the second quarter of 2026?
Glucotrack Inc achieved a return on average invested assets (ROI) of 843.28 % in its second quarter of 2026, this is above GCTK's average return on investment of 2.6%.
Glucotrack Inc invested over the 12 months ending in its second quarter of 2026 $1 million

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector only one company had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 13, from total ROI ranking in the first quarter of 2026 at 20.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -74.8 % 129.19 % - - 133.51 %
Y / Y Net Income Change TTM -68.92 % -36.28 % -1.43 % 169.99 % 496.35 %
Investment (TTM) in Millions -1 -1 3 3 7
Return On Investment (TTM) - - 372.04 % 460.92 % 683.82 %
GCTK's Overall Ranking # 13 # 20 # 19 # 11 # 8
Seq. Investment Change TTM -68.59 % -39.73 % -7.1 % 43.29 % 185.64 %
Seq. Net Income Change TTM -50.74 % -12.89 % -25.01 % -3.42 % 1.01 %
Net Income (TTM) in Millions 8 17 19 26 27

GCTK Company Profile >> Back to GCTK Roi Comparisons >> See Annual GCTK Return On Investment



Return On Investment GCTK's Ranking
Within: No.
Industry # 2
Sector # 2
Overall # 13

Return On Investment Statistics
High Average Low
1933.82 %
2.6 %
-2007.81 %
(Mar 31 2025)   (Sep 30 2017)







Financial Statements
Glucotrack Inc's II. Quarter Investments $ -1 Millions GCTK's Balance sheet
Glucotrack Inc's II. Quarter Income $ -4 Millions Quarterly GCTK's Income Statement
GCTK's Income by Division See GCTK's Income by Division


GCTK Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 3 5 3 1 5
Y / Y Investment Growth -34.19 % 37.25 % 138.11 % -73.52 % -41.89 %
Net Income in Millions 19 23 7 4 4
Y / Y Net Income Growth -14.2 % 218.4 % 60.02 % 9.05 % 50.85 %
Annual Return On Investment 632.56 % 485.23 % 209.17 % 311.23 % 75.57 %


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 632.56 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GCTK's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GCTK's Competitors
Subscribers only: Roi for Glucotrack Inc's Suppliers
Subscribers only: Return On Investment for GCTK's Customers

Other Ratios
GCTK's Roa GCTK's Inventory Turnover Ratio GCTK's Growth Rates GCTK's Dividend Statistics
GCTK's Profitability Ratios GCTK's Asset Turnover Ratio GCTK's Dividend Growth
GCTK's Roe GCTK's Valuation Ratios GCTK's Financial Strength Ratios GCTK's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Glucotrack Inc   843.28 %
Stablecoin Development Corporation  618.18 %
Omeros Corporation  198.34 %
Elutia Inc   191.75 %

Date modified: 2026-08-31T23:26:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.